Antroquinonol

 

Product Intro.

 

Golden Biotech has a phase II clinical trial of Antroquinonol for fighting COVID-19 pandemic. This phase II trial is a randomized, double blind and placebo controlled study to evaluate the safety and efficacy of Antroquinonol in mild-moderate COVID-19 hospitalized patients. Initial and interim results received a positive response from the Data Monitoring Committee (DMC) which also suggested that the Antroquinonol study be expanded to severe COVID-19 patients.